🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Researchers, clinicians, advocates, and people living with ALS from over 30 countries gathered at the 2025 Target ALS Annual Meeting—sharing bold ideas, collaborating and driving momentum towards breakthroughs. Sign up to learn more and see what's ahead: bit.ly/3GGRGTT

$250,000,000 for ALS. In our latest episode, we sat down with Target ALS's Dan Doctoroff who also lost his voice to ALS. With help from ElevenLabs, we talked about Dan raising $250MM for Target ALS, Dan's time as Deputy Mayor under Michael Bloomberg, and what is next in

For decades, the absence of reliable biomarkers has stalled progress in diagnosing and treating ALS. See how researchers funded by Target ALS are pioneering next-generation tools to better detect the pathology of a disruptive protein found in 97% of cases. bit.ly/43S8orj

At this year’s Target ALS Annual Meeting, Dr. Ajroud-Driss shared her journey—from her early days as a medical trainee in Tunisia to becoming a leading force in #ALSResearch at Northwestern University. Read the full conversation: bit.ly/3ZhNKiS

During this year’s Target ALS Annual Meeting, Dr. Robert McFarlane shared his vision for a new kind of research—one powered by machine learning, global collaboration, and a dataset of over 25,000 ALS patients. See his journey and groundbreaking work: bit.ly/43tgqIi

Dr. Leonard Petrucelli is a globally recognized leader in neurodegeneration and our longtime Scientific Advisor. He's been instrumental in shaping #ALSResearch and the very foundation of Target ALS. As he steps down from his role with us, we celebrate his partnership and vision.

What if the answers to #ALS and #FTD are hidden in the stretches of our DNA once dismissed as “junk”? Dr. Yini Li doesn’t just ask that question, she’s building her entire lab around it. Read about how she's charting new territory in #ALSResearch. bit.ly/4jPLdUz

This #FathersDay, we invite you to read a moving tribute from Ariel Doctoroff to her dad, our founder, Dan Doctoroff. ❤️ Read Ariel’s full tribute to her father at bit.ly/44fsEVc

Dr. Björn Oskarsson’s leads the Target ALS Global Natural History Study site at Mayo Clinic, where he’s turning biofluid samples into the key to faster breakthroughs, driven by urgency and collaboration. See how this is changing the future of #ALSResearch: bit.ly/43RLVvX

At our Annual Meeting, QurAlis shared promising results from early clinical trials of QRL-101, a potential therapy that could reshape how we treat #ALS by addressing a root feature of ALS and other neurological conditions. 👉 Sign up to learn more: bit.ly/3GGRGTT

We recently sat down with Dr. Cindy Ly to hear how personal passion and scientific rigor can change the course of #ALSResearch. Dr. Ly has made it her mission to ensure that every tissue sample tells a story and unlocks new insights. Hear from Dr. Ly: bit.ly/3HLsT1z

On #GlobalALSMNDAwarenessDay, we reaffirm our commitment to #ALS research without borders. Through AGRI, we’re powering global access to biofluids + data to drive real-time breakthroughs. Join the movement: targetals.org/agri/

At our Annual Meeting, Dr. Jenna Gregory shared how her team is bringing oncology-style precision to ALS—studying how T cells behave differently with #ALS. Her findings, through research we fund, offer clues for better treatment. Sign up to learn more: bit.ly/3GGRGTT

New Funding Opportunity: Springboard Fellowship The Target ALS Springboard Fellowship supports senior lab fellows pursuing careers in #ALS #FTD research transition to an independent academic tenure track or equivalent positions. Apply today: targetals.org/springboard-fe…

Last month, Target ALS was featured by @Intersection_Co on LinkNYC throughout New York City to celebrate #ALSAwarenessMonth. The campaign featured 5 New Yorkers, including our founder, Dan Doctoroff, who drive #ALSResearch. Read more about the campaign: bit.ly/40dg5Hr

During our Annual Meeting, Dr. Arti Patel from Novartis shared how a global team is pioneering a new way to track #ALS and #FTD. Sign up to see how their insights could pave the way for innovative tests to identify disease. targetals.org/join-us/

Our ALS Global Research Initiative is a global movement united in the spirit of #RadicalCollaboration and innovation. With every facet of this effort we’re breaking down barriers to accelerate discovery and bring hope to every corner of the world. bit.ly/3ZRz1eR.

Target ALS is funding a bold new wave of therapies aimed at TDP-43 pathology early in the disease process, with the potential to delay or even prevent symptoms. Read how we're taking aim at TDP-43: bit.ly/45ZZDxU #ALS #TDP43 #Neuroscience #EveryoneLives

Dr. Javier Oroz is using the Target ALS Biofluids Core to advance #ALSResearch by detecting misfolded TDP-43, a protein that becomes toxic in the vast majority of #ALS cases. See how your research can benefit from our no-strings attached resources: bit.ly/4ia7Zpl

The Target ALS Data Engine plays a crucial role in accelerating #ALSResearch by making high-value data accessible to scientists worldwide, with no strings attached. Get access to rich, curated datasets without IP restrictions or cost barriers today: bit.ly/4ia7Zpl